Table 2 Medians and interquartile ranges of ceramides in patients with and without acute kidney injury (AKI)

1.394 (1.092–1.766)

1.656 (1.200–2.231)

 < 0.001

1.989 (1.333–2.722)

2.411 (1.768–3.931)

 < 0.001

1.952 (1.512–2.564)

2.160 (1.585–3.447)

0.003

1.480 (1.061–1.966)

1.778 (1.264–2.458)

 < 0.001

1.094 (0.804–1.446)

1.036 (0.742–1.448)

0.459

0.849 (0.618–1.178)

0.870 (0.634–1.192)

0.452

0.837 (0.587–1.137)

0.725 (0.528–1.031)

0.011

2.932 (2.025–3.963)

3.645 (2.426–5.496)

 < 0.001

0.785 (0.541–1.164)

1.051 (0.765–1.614)

 < 0.001

0.749 (0.497–1.052)

0.736 (0.479–1.109)

0.996

0.832 (0.526–1.239)

0.803 (0.435–1.187)

0.458